The Surprising Power of Bacteria in the Vaginal Microbiome: How Lactobacillus is Crucial to Women’s Health
DOI:
https://doi.org/10.58445/rars.407Keywords:
vaginal microbiome, bacteria, loctobacillus, women's healthAbstract
The purpose of this review article is to highlight the role of beneficial bacteria in promoting a healthy vaginal microbiome. The article describes the mechanisms for maintaining a healthy vaginal microbiome, the symptoms of a “dysbiotic” (disrupted) vaginal microbiome, and an overview of the vaginal diseases that can occur from a disrupted bacterial ecosystem inside this organ. Additionally, it outlines how to promote a healthy vaginal microbiome through lifestyle choices and a summary of current treatments available to patients who suffer from bacteria-related vaginal infections.
References
References
Azie, N., Angulo, D., Dehn, B., & Sobel, J. D. (2020). Oral Ibrexafungerp: an investigational agent for the treatment of vulvovaginal candidiasis. Expert Opinion on Investigational Drugs, 29(9), 893-900. https://doi.org/10.1080/13543784.2020.1791820
Baldacci, F., Baldacci, M., & Bertini, M. (2020). Lactobacillus rhamnosus BMX 54+ Lactose, A Symbiotic Long-Lasting Vaginal Approach to Improve Women’s Health. International Journal of Women's Health, 1099-1104.
DOI: 10.2147/IJWH.S259311
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019). Estimation of direct healthcare costs of fungal diseases in the United States. Clinical Infectious Diseases, 68(11), 1791-1797.
https://doi.org/10.1093/cid/ciy776
Bitew, A., Abebaw, Y., Bekele, D., & Mihret, A. (2017). Prevalence of Bacterial Vaginosis and Associated Risk Factors among Women Complaining of Genital Tract Infection. International journal of microbiology, 2017, 4919404.
https://doi.org/10.1155/2017/4919404
Boahen A, Than LTL, Loke Y-L and Chew SY (2022) The Antibiofilm Role of Biotics Family in Vaginal Fungal Infections. Front. Microbiol. 13:787119. doi: 10.3389/fmicb.2022.787119
https://doi.org/10.3389/fmicb.2022.787119
Brown, H., & Drexler, M. (2020). Improving the Diagnosis of Vulvovaginitis: Perspectives to Align Practice, Guidelines, and Awareness. Population health management, 23(S1), S3–S12.
https://doi.org/10.1089/pop.2020.0265
Cateau, E., Rodier, M. H., & Imbert, C. (2008). In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth. Journal of antimicrobial chemotherapy, 62(1), 153-155
.https://doi.org/10.1093/jac/dkn160
Chandrashekhar, P., Minooei, F., Arreguin, W., Masigol, M., & Steinbach-Rankins, J. M. (2021). Perspectives on existing and novel alternative intravaginal probiotic delivery
methods in the context of bacterial vaginosis infection. The AAPS journal, 23(3), 66.
https://doi.org/10.1208/s12248-021-00602-z
Chee, W. J. Y., Chew, S. Y., & Than, L. T. L. (2020). Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Microbial cell factories, 19(1), 203.
https://doi.org/10.1186/s12934-020-01464-4
Centers for Disease Control and Prevention. (2013, August 29). Incidence, prevalence, and cost of sexually transmitted infections in the United States.
http://www.cdc.gov/std/stats/STI-Estimates-Fact-Sheet-Feb-2013.pdf
Gustin, A., Cromarty, R., Schifanella, L., & Klatt, N. R. (2021). Microbial mismanagement: how inadequate treatments for vaginal dysbiosis drive the HIV epidemic in women. Seminars in immunology, 51, 101482.
https://doi.org/10.1016/j.smim.2021.101482
Gupta, S., Kakkar, V., & Bhushan, I. (2019). Crosstalk between vaginal microbiome and female health: a review. Microbial pathogenesis, 136, 103696.
https://doi.org/10.1016/j.micpath.2019.103696
Ismatiloevna, Y. F. (2022). TREATMENT OF VAGINAL DYSBIOTIC DISORDERS IN PREGNANT WOMEN BEFORE CHILDBIRTH. World Bulletin of Public Health, 12, 86-89.
https://www.scholarexpress.net
Lehtoranta, L., Ala-Jaakkola, R., Laitila, A., & Maukonen, J. (2022). Healthy vaginal microbiota and influence of probiotics across the female life span. Frontiers in Microbiology, 13, 819958.
https://doi.org/10.3389/fmicb.2022.819958
Losa, F., Palacios, S., Rodríguez, S. P. G., Baquedano, L., Khorsandi, D., & Muñoz, M. J. (2022). Vaginal dysbiosis management and the efficacy of a non-hormonal hyaluronic acid-based vaginal gel (Palomacare®) as an adjuvant treatment: the Palomascopia survey. Obstet Gynecol Cases Rev, 9, 222.
DOI: 10.23937/2377-9004/1410222
Nappi, R. E., & Kokot-Kierepa, M. (2012). Vaginal Health: Insights, Views & Attitudes (VIVA)–results from an international survey. Climacteric, 15(1), 36-44.
https://doi.org/10.3109/13697137.2011.647840
Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S., & Barnabas, R. V. (2019). High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sexually transmitted diseases, 46(5), 304–311.
DOI: 10.1097/OLQ.0000000000000972
Qin, J., Saraiya, M., Martinez, G., & Sawaya, G. F. (2020). Prevalence of Potentially Unnecessary Bimanual Pelvic Examinations and Papanicolaou Tests Among Adolescent Girls and Young Women Aged 15-20 Years in the United States.
doi:10.1001/jamainternmed.2019.5727
Ravi, A., Pfeiffer, M. R., Rosner, Z., & Shea, J. A. (2017). Identifying health experiences of domestically sex-trafficked women in the USA: A qualitative study in Rikers Island jail.
https://doi.org/10.1007/s11524-016-0128-8
Qi, F., Fan, S., Fang, C., Ge, L., Lyu, J., Huang, Z., ... & Zhang, X. (2022). Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 Can Restore the Vaginal Health of Patients Recovering from Bacterial Vaginosis. medRxiv, 2022-12.
https://doi.org/10.1101/2022.12.21.22283705
Ravel, J., & Brotman, R. M. (2016). Translating the vaginal microbiome: gaps and challenges. Genome medicine, 8, 1-3.]
https://doi.org/10.1186/s13073-016-0291-2
Ross, J.D.C., Brittain, C., Anstey Watkins, J. et al. Intravaginal lactic acid gel versus oral metronidazole for treating women with recurrent bacterial vaginosis: the VITA randomized controlled trial.
https://doi.org/10.1186/s12905-023-02303-5
Rodríguez-Nava, C., Cortés-Sarabia, K., Avila-Huerta, M. D., Ortiz-Riaño, E. J., Estrada-Moreno, A. K., Alarcón-Romero, L. D. C., ... & Morales-Narváez, E. (2021). Nanophotonic sialidase immunoassay for bacterial vaginosis diagnosis. ACS Pharmacology & Translational Science, 4(1), 365-371.
DOI: 10.1021/acsptsci.0c00211
Saraf, V. S., Sheikh, S. A., Ahmad, A., Gillevet, P. M., Bokhari, H., & Javed, S. (2021). Vaginal microbiome: normalcy vs dysbiosis. Archives of Microbiology, 203, 3793-3802.
https://doi.org/10.1007/s00203-021-02414-3
Secor, W. E., Meites, E., Starr, M. C., & Workowski, K. A. (2014). Neglected parasitic infections in the United States: trichomoniasis.
doi: 10.4269/ajtmh.13-0723
Sobel, J. D., & Nyirjesy, P. (2021). Oteseconazole: an advance in treatment of recurrent vulvovaginal candidiasis. Future microbiology, 16(18), 1453-1461.
https://doi.org/10.2217/fmb-2021-0173
Superti, F., & De Seta, F. (2020). Warding off recurrent yeast and bacterial vaginal infections: Lactoferrin and lactobacilli. Microorganisms, 8(1), 130.
https://doi.org/10.3390/microorganisms8010130
Wrønding, T., Vomstein, K., Bosma, E. F., Mortensen, B., Westh, H., Heintz, J. E., ... & Nielsen, H. S. (2023). Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution, and live birth after recurrent pregnancy loss: a proof of concept case study. eClinicalMedicine.
Downloads
Posted
Categories
License
Copyright (c) 2023 Ashley Hurjak
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.